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Background: Spinal cord metastatic lesions affect a high number of cancer patients usually resulting in spinal cord
compression syndrome. A major obstacle in the research of spinal metastatic disease is the lack of a simple
reproducible animal model that mimics the natural course of the disease. In this study, we present a highly
reproducible rodent model that can be used for different types of cancers while mimicking the natural course of
human metastatic spinal cord compression syndrome.
Results: All sixteen Fisher 344 rats survived the dorsal approach intraosseous implantation of CRL-1666
adenocarcinoma cells and both rats survived the sham control surgery. By Day 13 functional analysis via the
modified Basso-Beattie-Bresnahan (BBB) locomotor rating scale showed significant decrease in motor function;
median functional score was 3 for the tumor group (p = 0.0011). Median time to paresis was 8.7 days post-operatively.
MR imaging illustrated repeated and consistent tumor formation, furthermore, onset of neurological sequale was
the result of tumor formation and cord compression as confirmed by histological examination.
Conclusions: Analysis of these findings demonstrates a repeatable and consistent tumor growth model for cancer
spinal metastases in rats. This novel rat model requires a less intricate surgical procedure, and as a result minimizes
procedure time while subsequently increasing consistency. Therefore, this model allows for the preclinical evaluation of
therapeutics for spinal metastases that more closely replicates physiological findings.
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A substantial number of cancer patients develop meta-
static lesions in the spinal vertebra, and are associated
with high rates of morbidity and mortality. Approxi-
mately 70% of patients with advanced breast or prostate
cancer, and 15% of lung cancer patients develop bone
metastasis [1]. Of these patients, 15 to 20% will develop
a metastasis to the vertebra with a significant proportion
presenting with symptoms including: pain, compression
fractures, anemia or neurologic sequalae, due to spinal
cord or nerve root compression. Once tumors have
metastasized they are usually incurable with less than
20% of patients surviving past 5 years [1,2].* Correspondence: zzibly@yahoo.com
1Radiation Oncology Branch, National Cancer Institute, National Institutes of
Health, 10 Center Drive, Bethesda, MD 20892, USA
2Surgical Neurology Branch, National Institute of Neurological Disorders and
Stroke, National Institutes of Health, Bethesda, MD 20892, USA
Full list of author information is available at the end of the article
© 2012 Zibly et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orAlthough metastatic spinal cord compression is a
major cause of morbidity and mortality, a key obstacle
in the study of this disease is the lack of reliable, prac-
tical and reproducible animal models to allow for the ex-
ploration of new treatment methodologies. Several
researchers have attempted to replicate the disease
effects for spinal metastases; however, these models have
several limitations, such as high mortality rates, the use
of rare metastatic routes for cell implantation, and wide
ranges for symptom onset [3-6]. Better models are
needed to provide more reliable predictions of novel
therapeutic agents in animals, and their subsequent effi-
cacy in humans. This preliminary data is essential for
the investigation of new therapeutic agents, and the
translation of laboratory advances to human cancer care.
In this study, we demonstrate a simple and highly re-
producible model for spinal intraosseous metastatic can-
cer using the breast adenocarcinoma cell line CRL-1666
in Fisher 344 rats. Our model replicates the natural
course of human metastatic spinal cord compressiond. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tumor implantation, study the timing of functional
motor loss, and observe tumor growth patterns using




Eighteen rats were used in this study, with all 16 receiv-
ing CRL-1666 tumor implants and 2 rats receiving sham
injections. All 18 animals survived the surgical proced-
ure and the immediate postoperative period without
complication. Functional assessment was monitored
using the modified BBB scale as described. The graph in
Figure 1 illustrates the median modified BBB score over
time. The mixed polynomial model was implemented to
analyze the functional status of the rats from the date of
the surgical procedure until the MR imaging. The me-
dian time to paralysis was 8.7 days. Thirteen days post-
operatively the median modified BBB score was 3 for the
tumor group, while the modified BBB score for the
Sham group was consistently 9 (p = 0.0011; 95% Confi-
dence Interval; Wilcoxon signed-rank test).
Imaging
As shown in Figure 2, the growth pattern of the
implanted tumor was circumferential in the epidural
space, and included destruction of the inner cortex of
the lamina. As a result, the growing tumor mass exerted
pressure on the spinal cord and evoked neurological
sequalae. A part of the tumor grew posterior to the lam-
ina with neither clinical nor neurologic consequence.
Histopathological examination
As shown in Figure 2C and D, the gross anatomy and H
& E studies of the animals that were transplanted withFigure 1 The median BBB score of treatment group over time from dthe CRL-1666 tumor cells, revealed a well circumscribe
highly cellular lesion invading and destroying the inner
cortx of the vertebral laminae. Also we could note a well
area where the tumor was compressing the spinal cord
and changing its shape. The tumor showed typical histo-
pathological appearance of adenocarcinoma.
Discussion
In this study, we describe a novel rat model for spinal
metastases; describe the surgical technique for tumor
implantation, in addition to, the functional, MR and
histological findings. We found that rats implanted by
this surgical technique with CRL-1666, a breast adeno-
carcinoma cell line exhibited paresis in 8.7 days, with a
consistent decrease in BBB score. Animals that under-
went sham surgery recovered uneventfully and main-
tained a maximum BBB score throughout the study.
A number of researchers have tried to establish a rele-
vant animal model of spinal vertebral and epidural meta-
static cancer. Ushio et al described a model employing
paraspinal injection of tumor cells [3,4]. This model
requires local invasion of the spine by tumor cells, an in-
frequent mode of spinal metastasis, rather than tumor
growth from within the bone of the vertebra. The patho-
physiology of this paraspinal injection is completely dif-
ferent than the typical intraosseous metastasis because it
is believed that the tumor invades the vertebra from the
paraspinal tissue not from the vasculature. In addition,
the onset of symptoms of paraplegia required 3 to 4
weeks, restricting the efficiency of the model and its sub-
sequent research potential.
In an attempt to address these limitations Mantha, et
al demonstrated a model of spinal metastasis using a
trans-abdominal vertebral implant of a breast cancer cell
line [5]. Despite onset of paresis occurring within 14 to
16 days post surgery, an improvement upon the Ushioate of surgery until MR imaging. Cut-off value was a BBB score of 3.
Figure 2 T1 weighted post contrast MRI showing the destruction of the inner cortex of the laminae and cord compression by the
tumor (red arrow in both frames). (A) Higher magnification of the spinal cord and invading tumor compressing the cord (B) Gross anatomical
section of rat spinal cord showing tumor invasion and destruction of the vertebra as well as spinal cord compression (outlined box). (C)
Histological cross-section of rat vertebra exhibiting tumor infiltration (T; stained purple) into the spinal canal and vertebra (pink) (D).
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must perform a delicate and lengthy procedure to separate
the great vessels from the vertebral column. Moreover, a
high rate of complication, 11%, and mortality was seen.
This is likely due to the complex dissection in the retro-
peritoneal space required for obtaining adequate exposure
to the vertebral column. Strub et al. demonstrated ametastatic renal cell carcinoma model via intra cardiac in-
jection of tumor cells [7]. The limitations of this model
were the variable time to disease and the unpredictable
location of metastatic growth.
Here we described a novel, simple, and reproducible
technique designed to better model spinal intraosseous
metastatic cancer. Following intraosseous implantation
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findings of epidural spinal cord compression were ac-
companied by neurologic findings of progressive para-
paresis. The median time frame to develop paralysis was
15 to 18 days with a median value of 8.7 days; thus this
model carries a high degree of consistency, illustrated by
the tightly grouped decrease in functional score, and can
be used as a tool for in vivo studies designed to evaluate
the pathophysiology and treatment of spinal metastatic
cancers.
One possible explanation for the observed increased
rapid onset of paralysis can be the result of the chosen
implantation site. Previous implantation sites used by
Mantha et al. injected tumor cells into a bur in a much
thicker part of the vertebrae [5]. Our bur site near the
spinal process requires the tumor to grow through much
less bone to reach and compress the spinal cord. The
dorsal approach our group implemented compared to a
ventral approach used by Mantha et al. may further help
to explain this observed phenomenon [5].
The change in the neurological status of the animals,
as described using the modified BBB scale, correlated
well with the findings in imaging studies. The more
pressure the tumor imposed on the spinal cord, as
assessed by anatomical findings the more severe the
neurologic deficit the animal manifested. Often the
tumor was seen eliminating the subarachnoid space and
inducing focal spinal cord edema. The tumor invasion
and subsequent spinal cord compression confirmed by
histology further validated the observed neurological
change.
These findings mimic the recognized presentation and
step-wise progression of spinal cord compression syn-
drome that is seen in humans suffering from metastatic
spinal cancer [8]. This step-wise progression suggests
like the model created by Mantha et al., [5] three phases
of disease progression: (1) the primary or initial phase
marked by similar modified BBB scores to controls; (2)
the initial onset phase in which there is a slight deficits
observed, and (3) the rapid progression to paralysis.
There were no surgical complications, and all animals
survived the procedure and developed the predicted
neurological sequelae of the disease.
Conclusions
The current model for spinal metastatic cancer involves
various tumor cell lines including breast adenocarcin-
oma, prostate cancer, and lung cancer. This improved
model is capable of consistent and reproducible tumor
growth which mimics spinal cord compression and asso-
ciated neurological sequale. Furthermore, the surgical
procedure to implant tumor cells intraosseously is much
simpler, well-tolerated, and requires less technical skill
and surgical time when compared to current models.This model reliably recapitulates the human syndrome,
and can be used with various tumor cell lines including
breast adenocarcinoma, prostate cancer, and lung can-
cer. The described in vivo model can be capable of sup-
porting preclinical research that advances understanding
and treatment of spinal metastasis.
Methods
Animal and experimental design
Eighteen 10-12 week old Fischer 344 female rats weigh-
ing between 170 and 200 grams were used in this study.
Sixteen underwent surgery and implantation of a CRL-
1666 adenocarcinoma tumor sample and two were
placed in the sham control group. (ATCC, Manassas
VA) All animals were maintained in a standard two rats
per cage environment, and given free access to water
and food. All experimental protocols were approved by
the Animal Care and Use Committee of the National
Institutes of Health and performed under the ARRIVE
guidelines [9].
Instrumentation
Procedures were done under direct visualization via sur-
gical telescopes. Surgical instruments included N0 7 for-
ceps, No 15 scalpel blades, a mini Friedman bone
rongeur, and a bipolar cautery device. A high-speed sur-
gical drill with a 1 mm burr was used to remove the
bony cortex of the lamina (Fine Science Tools, CA,
USA). Muscle was closed sutured with 3-0 Vicryl suture
(Ethicon, NJ, USA). Skin was closed using 3-0 silk suture
(Look TM, USA).
Tumor cell line/flank injection
The CRL-166 mammary adenocarcinoma cell line
(American Type Culture Collection, Manassas, VA,
USA) was used for this study. This cell line was estab-
lished at the EG&G Mason Research Institute from a
transplantable rat ascites tumor derived from the 13762
solid mammary adenocarcinoma. Cell cultures were
grown in McCoy's 5a Medium modified with 10% fetal
bovine serum (Gibco, Invitrogen). Cultures are main-
tained in 5% CO2 at 37°C and split approximately every
3 days.
A subcutaneous tumor was used as the source of the
solid tumor grafts. Rats were anesthetized as described
below and received a subcutaneous injection of 15x106
CRL-1666 cells into the right hind limb. At day 12 fol-
lowing injection, animals were sacrificed, and the tumor
was resected and sliced into 0.5 X 0.5 cm pieces to be
suitable for intraosseous implantation.
Anesthesia monitoring and imaging
MRI experiments were performed on a 7 Tesla (Bruker
Avance, Billerica, MA, USA), 21 cm horizontal scanner.
Figure 3 Animal positioning and preparation prior to surgical
procedure. The thoraco-lumbar back is shaved, prepared and the
mid-line skin above the spinal process is marked.
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placed on a flat MRI compatible cushion and then
mounted in a 72 mm (transmit receive) / radio fre-
quency volume coil. The body core temperature was
maintained at 37°C using a warm air blower and moni-
tored by means of a rectal temperature probe. A pres-
sure transducer (SA Instruments, Inc., NY, USA) was
placed on the rats to monitor breathing rate (60±10 per
min) under anesthesia; this respiratory signal was also
used to synchronize image acquisition to minimize re-
spiratory artifacts. Analgesia was provided by Maloxicam
1.5 mg/kg for 3 days following the surgical procedure.
MR images of three mutually perpendicular slices were
acquired through the spine as scouts. The pilot images
were used to obtain a series of, 0.75 mm thick, T1
weighted gradient echo images in two orthogonal axes,
coronal (15 slices, in-plane resolution = 121 μm, Echo
Time [TE]/Repetition Time [TR] = 4.5 ms/200 ms,
Number of averages [NA] = 16) and sagittal (9 slices, in-
plane resolution = 121 μm, TE/ TR = 4.5 ms/200 ms,
NA = 16) planes encompassing the spinal cord region
and the tumor. These images were used to identify the
region of tumor invasion to the spinal cord and 15 axial
images were acquired (slice thickness = 0.75 mm, in-
plane resolution = 100 μm, TE/ TR = 4.5 ms/200 ms,
NA = 16) to visualize the tumor and spinal cord.Surgical technique
Following anesthesia, the animal was positioned it the
prone position (Figure 3). The thoraco-lumbar back was
shaved and prepared with betadine and alcohol swab. A
2-cm midline skin incision above the spinal process was
done and a skin retractor was used. A sub-periosteal
blunt dissection of the spinalis muscle was done bilat-
erally to expose the lamina (Figure 4A). The spinous
process was excised using the bone rounger. A high-
speed drill was used to perform a partial laminectomy,
drilling the outer cortex, and leaving the internal cortex
of the lamina intact (Figure 4B). The cavity was 2-3 mm
deep and 4-6 mm wide. The tumor piece was cut to fit
the cavity size and subsequently inserted into the cavity.
It was then covered with bone wax and the muscles were
closed using an interrupted 3-0 Vicryl suture (Figure 5).
The skin was closed with a running 3-0 nylon suture.Sham surgery
In the rodents undergoing sham surgery, all the afore-
mentioned steps were taken expect the implantation of
Figure 4 Skin incision above the spinal process and exposing the lamina of the vertebra bilateral. (A) Preparing the lamina for tumor
transplant, drilling of the right lamina outer cortex after resection of the spinous process. (B).
Figure 5 Artist rendering of surgical procedure. (A) Drilling of the outer cortex of the lamina. (B) Implantation of the tumor cells and covering
by bone wax. (C) Tumor growth and spinal cord pressure.
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Table 1 Modified Basso-Beattie-Bresnahan rating scale
Score Clinical symptoms
0 No ankle movement
1 Slight ankle movement
2 Extensive ankle movements
3 Plantar placing of the paw with or without weight support
-OR-
Occasional, frequent or consistent dorsal stepping but no
plantar stepping
4 Occasional plantar stepping
5 Frequent or consistent plantar stepping, no coordination
-OR- Frequent or consistent plantar stepping, some
coordination, paws rotated at initial contact and lift off
6 Frequent or consistent plantar stepping, some coordination,
paws parallel at initial contact -OR- Frequent or consistent
plantar stepping, mostly coordinated, paws rotated at initial
contact and lift off
7 Frequent or consistent plantar stepping, mostly coordinated,
paws parallel at initial contact and rotated at lift off –OR-
Frequent or consistent plantar stepping, mostly coordinated,
paws parallel at initial contact and lift off , and severe trunk
instability
8 Frequent or consistent plantar stepping, mostly coordinated,
paws parallel at initial contact and lift off , and mild trunk
instability –OR- Frequent or consistent plantar stepping,
mostly coordinated, paws parallel at initial contact and lift
off, and normal trunk stability and tail down or up & down
9 Frequent or consistent plantar stepping, mostly coordinated,
paws parallel at initial contact and lift off , and normal trunk
stability and tail always up
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bone wax as described.Tissue and histopathological processing
Following animal euthanasia, the vertebral column was
removed intact and fixed in 10% buffered neutral forma-
lin. Bone was decalcified in a formic acid/sodium citrate
solution. The tumor and vertebra were trimmed in cross
section, embdedded in paraffin, sectioned at 5 microns
and stained with hematoxylin and eosin.Functional assessment and statistical analysis
A single investigator assessment was done using a modi-
fied Basso-Beattie-Bresnahan (BBB) locomotor rating
scale assessed daily Hind limb motor function (Table 1)
[10]. Based on the animal’s gait, a score between 0 and 9
was assigned according to Table 1. Once the animal
received a BBB score of 3 (paraparetic), they were
anesthetized and taken to MR imaging. The raw neuro-
logical scores were summarized as the median BBB
scores. The clinical significance of the change in neuro-
logical score was calculated using the Mixed Polynomial
model. Column statistical analysis was done on Graph-
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